by palligoelme@gmail.com | May 22, 2025 | Clinical Trials
Conditions: Triple-Negative Breast Cancer (TNBC); Neoadjuvant Chemotherapy; Chemotherapy Effects Interventions: Drug: nab-paclitaxel, carboplatin, and bemotuzumab; Drug: epirubicin, cyclophosphamide, and bemotuzumab Sponsors: Zhejiang Provincial People’s...
by palligoelme@gmail.com | May 21, 2025 | Clinical Trials
Conditions: Granulomatosis With Polyangiitis; Microscopic Polyangiitis (MPA) Interventions: Drug: Cyclophosphamide; Drug: Standard of Care (SOC); Drug: Prednisone; Drug: Rituximab (R) Sponsors: Ottawa Hospital Research Institute Not yet recruiting Conditions:...
by palligoelme@gmail.com | May 21, 2025 | Clinical Trials
Conditions: Multiple Sclerosis Interventions: Other: Mobile Health App for Neuropathic Pain Management in MS Sponsors: Meryem Kocaslan Toran; Uskudar University; The Scientific and Technological Research Council of Türkiye (TÜBİTAK) Not yet recruiting Conditions:...
by palligoelme@gmail.com | May 21, 2025 | Clinical Trials
Conditions: Lacrimal Stenosis of Both Eyes Interventions: Procedure: lacrimal deroofing Sponsors: Benha University Completed Conditions: Lacrimal Stenosis of Both Eyes Interventions: Procedure: lacrimal deroofing Sponsors: Benha University...
by palligoelme@gmail.com | May 21, 2025 | Clinical Trials
Conditions: Takayasu Arteritis; Behcet Disease; Quality of Life Sponsors: Uşak University; Pamukkale University Enrolling by invitation Conditions: Takayasu Arteritis; Behcet Disease; Quality of Life Sponsors: Uşak University; Pamukkale University Enrolling by...
